Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

Fig. 3

Validation of prognostic value of COL3A1, GPR158 and PITHD1 using KM plotter. Kaplan-Meier plots showing overall survival in HGSC and EC for a) COL3A1 (n = 1656 patients), b) GPR158 (n = 655 patients) and b) PITHD1 (n = 655 patients). Red: patient samples with expression levels above the median, black: patient samples with expression levels below the median. P values less than 0.05 were considered significant. Number-at-risk is indicated below the main plot. Hazard ratio (HR), 95% confidence interval, log rank P value were calculated using Cox proportional hazard model and log-rank tests, respectively

Back to article page